AP NEWS
Click to copy
Press release content from BusinessWire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Global Diabetic Nephropathy Market 2018-2022 | 34% CAGR Projection over the Next Four Years | Technavio

December 27, 2018

LONDON--(BUSINESS WIRE)--Dec 27, 2018-- analysts forecast the global diabetic nephropathy market to grow at a CAGR of nearly 34% during the forecast period, according to their latest market research report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181227005118/en/

Technavio has released a new market research report on the global diabetic nephropathy market for the period 2018-2022. (Graphic: Business Wire)

The rise in the incidence of diabetes is one of the major trends being witnessed in the . Globally, there has been a rise in the incidence and prevalence of diabetes, which has resulted in the occurrence of chronic kidney diseases in patients. In 2014. around 422 million people were diagnosed with diabetes, and the global prevalence of diabetes increased to 8.5%. The main factors for the increase in diabetes include increasing urbanization and an increase in risk factors like obesity, lifestyle, and dietary changes.

This report is available at a USD 1,000 discount for a limited time only:

According to Technavio analysts, one of the key factors contributing to the growth of the global diabetic nephropathy market is the increasing incidence of diabetic nephropathy among diabetic patients:

Global diabetic nephropathy market: Increasing incidence of diabetic nephropathy among diabetic patients

In the past years, there has been an increase in diabetic nephropathy among diabetic patients. Diabetic nephropathy is the primary cause of end-stage kidney disease globally. About 30%-40% of patients with diabetes develop diabetic nephropathy. In one study, it was observed that the incidence of diabetic nephropathy was much higher in freshly diagnosed cases of type 2 diabetes patients. The factors associated with the rise of incidence of diabetic nephropathy are hypertension, hypercholesterolemia, and obesity.

According to a senior analyst at Technavio for research on infectious and rare diseases, “Lack of awareness in public and the use of alternative medical practices have led to an increase in the incidence of diabetic nephropathy, especially in developing countries. Therefore, due to the increase in the incidence of diabetic nephropathy among diabetic patients offers a huge opportunity to the manufactures for the development of new and more effective drugs. Thus. boosting the growth of the global diabetic nephropathy market.”

Global diabetic nephropathy market: Segmentation analysis

The global diabetic nephropathy market research report provides market segmentation by type of disease (class I, class II, class III, and class IV), and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

The Americas led the market in 2017 with a market share of nearly 47%. This region is expected to dominate the market through 2022.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market ecosystem Market characteristics Market segmentation analysis

Market Sizing

Market definition Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

Regional comparison Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

Vendors covered Vendor classification Market positioning of vendors Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20181227005118/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: HEALTH FITNESS & NUTRITION INFECTIOUS DISEASES PHARMACEUTICAL DIABETES

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 12/27/2018 07:43 AM/DISC: 12/27/2018 07:42 AM

http://www.businesswire.com/news/home/20181227005118/en

All contents © copyright 2019 The Associated Press. All rights reserved.